Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PEAKO LIMITED Director's Dealing 2020

Oct 13, 2020

65567_rns_2020-10-13_659d138b-e43b-4928-ae54-40fb978439c2.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change in Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01. Amended 01/01/11
Name of entity:PEAKO LIMITED
ABN:79 131 843 868
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of DirectorDr Darryl James Clark
Date of last notice1 May 2020
Part 1 - Change of director’s relevant interests in securities
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.Introduced 30/09/01. Amended 01/01/11 Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.Introduced 30/09/01. Amended 01/01/11
Name of entity:PEAKO LIMITED
ABN:79 131 843 868
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of DirectorDr Darryl James Clark
Date of last notice1 May 2020
Part 1 - Change of director’s relevant interests in securities
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Direct or indirect interest Direct and Indirect
Nature of indirect interest(including registered holder) 1. Dr Darryl James Clark2. Mrs Undarmaa Baatarchuluun
Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change 14 October 2020
No. of securities held prior to change 1. 1,000,000 ordinary shares fully paid2. 1,000,000 - 28 Nov 22 options exerciseable at $0.04 (4 cents)2. 1,000,000 - 18 Mar 21 options exerciseable at $0.05 (5 cents)
Class Ordinary shares fully paid
Number acquired 1. 200,000 ordinary shares fully paid1. 100,000 - 30 June 22 options exerciseable at $0.055 (5.5 cents)
Number disposed Nil
Value/Consideration $6,400
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change 1. 1,200,000 ordinary shares fully paid2. 1,000,000 - 28 Nov 22 options exerciseable at $0.04 (4 cents)2. 1,000,000 - 18 Mar 21 options exerciseable at $0.05 (5 cents)1. 100,000 - 30 June 22 options exerciseable at $0.055 (5.5 cents)
Nature of changeExample: on-market trade off-market trade exercise of options issue of securities under dividend reinvestment plan participation in Rights issue participation
, , , ,buy-back
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change in Director's Interest Notice

Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change Part 3 –[+] Closed period Were the interests in the securities or contracts detailed above traded during a[+] closed N/A period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011